NCT05898750

Brief Summary

The Antidiabetic potential of Hyphaene thebaica fruits and Moringa oleifera leaves will be investigated in diabetic patients (type 2). The patients will be maintained on tea of both drugs for 6 weeks. The fasting blood glucose levels of patients will be checked on a daily basis. Other blood biomarkers will be also reported such as insulin concentration, Lipid profile, liver enzymes, c-peptide and glycated hemoglobin

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at P25-P50 for early_phase_1 diabetes

Timeline
Completed

Started Apr 2023

Shorter than P25 for early_phase_1 diabetes

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 22, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 22, 2023

Completed
21 days until next milestone

First Posted

Study publicly available on registry

June 12, 2023

Completed
10 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 22, 2023

Completed
8 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
Last Updated

September 26, 2023

Status Verified

September 1, 2023

Enrollment Period

2 months

First QC Date

May 22, 2023

Last Update Submit

September 24, 2023

Conditions

Diabetes

Outcome Measures

Primary Outcomes (1)

  • Blood glucose level

    measured by fast blood test

    3 months

Secondary Outcomes (4)

  • blood level of lipid profile

    two weeks

  • Liver enzymes

    two weeks

  • C-peptide level

    two weeks

  • Insulin level

    two weeks

Study Arms (2)

experimental group

EXPERIMENTAL
Dietary Supplement: MorDom

Control group

NO INTERVENTION

Interventions

MorDomDIETARY_SUPPLEMENT

oral powder in tea bags contains 4gm twice daily (equal concentration of each drugs)

experimental group

Eligibility Criteria

Age30 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • diabetic patients type 2

You may not qualify if:

  • liver failure
  • heart failure
  • renal failure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Soad A. Mohamad

Minya, 05673, Egypt

Location

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical professor

Study Record Dates

First Submitted

May 22, 2023

First Posted

June 12, 2023

Study Start

April 22, 2023

Primary Completion

June 22, 2023

Study Completion

June 30, 2023

Last Updated

September 26, 2023

Record last verified: 2023-09

Locations

EG(1)